Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & PerspectivesShorts
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement
Opinion|Videos|September 19, 2024

The CLARIFY Trial Design and Objectives for PSMA Imaging

Author(s)Michael Gorin, MD

Michael Gorin, MD discusses the impact of next-day imaging and the potential imaging improvements as physicians await the results of the CLARIFY trial.

Advertisement

Episodes in this series

EP. 1 PSMA PET Imaging: The Landscape and Current Challenges
EP. 1 PSMA PET Imaging: The Landscape and Current Challenges
EP. 2 Emerging Copper-Based Developments in PSMA Imaging
EP. 2 Emerging Copper-Based Developments in PSMA Imaging
EP. 3 COBRA AND PROPELLER: Background and Results of Prior PSMA Imaging Trials
EP. 3 COBRA AND PROPELLER: Background and Results of Prior PSMA Imaging Trials
EP. 4 The CLARIFY Trial Design and Objectives for PSMA Imaging
Now Playing
EP. 4 The CLARIFY Trial Design and Objectives for PSMA Imaging
EP. 5 Potential Impact of Forthcoming CLARIFY Trial Results
EP. 5 Potential Impact of Forthcoming CLARIFY Trial Results
Advertisement
Enhanced Detection in Prostate Cancer: The Promise of 64Cu-SAR-bisPSMA for Improved Imaging and Recurrence Reduction

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies
Multimedia

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

View more
Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis
Video

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

View more
Advertisement
Advertisement

Trending on Urology Times

1

AI-generated profiles impersonate female urologists to market ED products online

2

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

3

Doublet or triplet? Urologists weighs in on mCSPC options

4

John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC

5

Alternative BCG strains may help address ongoing supply challenges in NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us